Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Significance01:37

Statistical Significance

Once data is collected from both the experimental and the control groups, a statistical analysis is conducted to find out if there are meaningful differences between the two groups. A statistical analysis determines how likely any difference found is due to chance (and thus not meaningful). In psychology, group differences are considered meaningful, or significant, if the odds that these differences occurred by chance alone are 5 percent or less. Stated another way, if we repeated this...
Significance Testing: Overview01:04

Significance Testing: Overview

Significance testing is a set of statistical methods used to test whether a claim about a parameter is valid. In analytical chemistry, significance testing is used primarily to determine whether the difference between two values comes from determinate or random errors. The effect of a particular change in the measurement protocol, analyst, or sample itself can cause a deviation from the expected result. In the case of a suspected deviation/outlier, we need to be able to confirm mathematically...
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Statistical Hypothesis Testing01:16

Statistical Hypothesis Testing

Hypothesis testing is a critical statistical procedure facilitating informed, evidence-based decisions. It begins with a hypothesis, which is a tentative explanation, or a prediction about a population parameter. This hypothesis can be either a null hypothesis (H0), indicating no effect or difference, or an alternative hypothesis (Ha), suggesting an effect or difference.
Statistical significance measures the probability that an observed result occurred by chance. If this probability, known as...
Critical Region, Critical Values and Significance Level01:16

Critical Region, Critical Values and Significance Level

The critical region, critical value, and significance level are interdependent concepts crucial in hypothesis testing.
In hypothesis testing, a sample statistic is converted to a test statistic using z, t, or chi-square distribution. A critical region is an area under the curve in  probability distributions demarcated by the critical value. When the test statistic falls in this region, it suggests that the null hypothesis must be rejected. As this region contains all those values of the test...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical impact of medication reconciliation on physicians' treatment policies at outpatient clinics: a cross-sectional study.

BMC health services research·2026
Same author

Polyneuropathy in kidney transplant recipients: a cross-sectional study in Groningen, the Netherlands.

BMJ open·2026
Same author

Incidence and prevalence of small fibre neuropathy in the Netherlands: a multiple system estimation study.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Epimutation analysis reveals involvement of SLIT2/ROBO signaling pathway in painful diabetic neuropathy.

Human genomics·2026
Same author

The Rasch-transformed gastrointestinal symptoms rating scale in myotonic dystrophy type 1 (RT-GSRS-DM1).

Journal of neuromuscular diseases·2026
Same author

287th ENMC international workshop: Harmonization and federated analysis of myotonic dystrophy registries to model heterogeneous disease trajectories. Hoofddorp, the Netherlands, 28-30 March 2025.

Neuromuscular disorders : NMD·2025

Related Experiment Videos

[Statistical significance or clinical relevance?].

Els K Vanhoutte1, Catharina G Faber, Ingemar S J Merkies

  • 1Maastricht Universitair Medisch Centrum, afd. Neurologie, Maastricht, the Netherlands. els@van-houtte.net

Nederlands Tijdschrift Voor Geneeskunde
|December 24, 2010
PubMed
Summary

The minimal clinically important difference (MCID) is crucial for assessing treatment effectiveness. One study showed statistical significance without clinical relevance, while another demonstrated both statistical and clinical importance for IGIV in polyneuropathy.

Related Experiment Videos

Area of Science:

  • Clinical Trials
  • Neurology
  • Biostatistics

Context:

  • Evaluating treatment efficacy requires assessing both statistical significance and clinical relevance.
  • The concept of Minimal Clinically Important Difference (MCID) provides a framework for determining clinical relevance.
  • Two studies are examined to illustrate the application and importance of MCID in clinical research.

Purpose:

  • To evaluate the concept of Minimal Clinically Important Difference (MCID) in clinical research.
  • To assess whether statistically significant treatment effects translate into clinically meaningful improvements for patients.
  • To highlight the importance of considering MCID alongside statistical significance in interpreting trial results.

Summary:

  • A randomized trial in Parkinson's disease demonstrated statistical differences with rasagiline but did not consider MCID, questioning the clinical relevance.
  • A separate large trial in chronic inflammatory demyelinating polyneuropathy (CIDP) defined MCIDs using multiple methods.
  • This CIDP trial showed statistically significant and clinically relevant benefits of intravenous immunoglobulin (IGIV) over placebo, confirmed by various MCID thresholds.

Impact:

  • Emphasizes the necessity of incorporating MCID assessments in clinical trials to ensure reported benefits are meaningful to patients.
  • Suggests that statistical significance alone is insufficient for claiming treatment effectiveness.
  • Provides evidence for the clinical utility of IGIV in CIDP when assessed against established MCID values.